Galera Therapeutics Inc.

8.96-0.2600-2.82%Vol 97.54K1Y Perf -0.44%
Jun 15th, 2021 16:00 DELAYED
BID8.95 ASK9.00
Open9.16 Previous Close9.22
Pre-Market- After-Market-
 - -  - -%
Target Price
16.00 
Analyst Rating
Strong Buy 1.00
Potential %
78.57 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap226.28M 
Earnings Rating
Price Range Ratio 52W %
33.84 
Earnings Date
9th Aug 2021

Today's Price Range

8.849.22

52W Range

5.8715.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
0.45%
1 Month
15.02%
3 Months
-19.50%
6 Months
-18.25%
1 Year
-0.44%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GRTX8.96-0.2600-2.82
AAPL129.64-0.8400-0.64
GOOG2 520.66-6.3800-0.25
MSFT258.36-1.5300-0.59
XOM64.332.26003.64
WFC45.460.31000.69
JNJ164.49-0.8800-0.53
FB336.75-0.0200-0.01
GE13.540.07000.52
JPM155.18-2.3900-1.52
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.82-0.758.54
Q04 2020-0.66-0.80-21.21
Q03 2020-0.77-0.6910.39
Q02 2020-0.75-0.750.00
Q01 2020--0.74-
Q04 2019--1.31-
Q03 2019-0.45-51.43-11 328.89
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2021
Estimated EPS Next Report-0.79
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume97.54K
Shares Outstanding25.25M
Trades Count1.09K
Dollar Volume523.64K
Avg. Volume369.87K
Avg. Weekly Volume154.65K
Avg. Monthly Volume165.92K
Avg. Quarterly Volume603.06K

Galera Therapeutics Inc. (NASDAQ: GRTX) stock closed at 8.96 per share at the end of the most recent trading day (a -2.82% change compared to the prior day closing price) with a volume of 97.54K shares and market capitalization of 226.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 32 people. Galera Therapeutics Inc. CEO is J. Mel Sorensen.

The one-year performance of Galera Therapeutics Inc. stock is -0.44%, while year-to-date (YTD) performance is -12.41%. GRTX stock has a five-year performance of %. Its 52-week range is between 5.87 and 15, which gives GRTX stock a 52-week price range ratio of 33.84%

Galera Therapeutics Inc. currently has a PE ratio of -3.00, a price-to-book (PB) ratio of 29.39, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -74.04%, a ROC of -320.76% and a ROE of -350.79%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Galera Therapeutics Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.79 for the next earnings report. Galera Therapeutics Inc.’s next earnings report date is 09th Aug 2021.

The consensus rating of Wall Street analysts for Galera Therapeutics Inc. is Strong Buy (1), with a target price of $16, which is +78.57% compared to the current price. The earnings rating for Galera Therapeutics Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Galera Therapeutics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Galera Therapeutics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.28, ATR14 : 0.46, CCI20 : 72.77, Chaikin Money Flow : 0.00, MACD : 0.31, Money Flow Index : 72.09, ROC : 6.41, RSI : 61.64, STOCH (14,3) : 69.77, STOCH RSI : 0.00, UO : 52.22, Williams %R : -30.23), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Galera Therapeutics Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Galera Therapeutics Inc.

Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.

CEO: J. Mel Sorensen

Telephone: +1 610 725-1500

Address: 2 W Liberty Boulevard, Malvern 19355, PA, US

Number of employees: 32

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

42%58%

Bearish Bullish

50%50%

Bearish Bullish

61%39%

News

Stocktwits